Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Eliadis

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Australian and New Zealand Journal of Ophthalmology|May 1, 1993
Interferon for subfoveal choroidal neovascularisationE Groeneveld, P Eliadis
Emergency Medicine (Fremantle, W.A.)|March 21, 2002
Angioedema in the emergency department: a presentation of lymphomaJ Wellwood, K Taylor, S Wright, et al.
Cancer Nursing|June 1, 1995
Psychosocial benefits of postmastectomy lymphedema therapyB R Mirolo, I H Bunce, M Chapman, et al.
Leukemia & Lymphoma|December 29, 1999
Long-term interferon-alpha 2A does not induce sustained hematologic remission in younger patients with essential thrombocythemiaM Bentley, K Taylor, A Grigg, et al.
Australian and New Zealand Journal of Medicine|April 14, 1999
Efficacy, safety and tolerability of anagrelide in the treatment of essential thrombocythaemiaA K Mills, K M Taylor, S J Wright, et al.
Leukemia Research|March 10, 1999
Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factorJ Morton, P Mollee, K Taylor, et al.
Leukemia|August 23, 2001
Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemiaK Bradstock, J Matthews, G Young, et al.
Leukemia & Lymphoma|September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)R M Lowenthal, K F Bradstock, J P Matthews, et al.
British Journal of Haematology|October 1, 1996
High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study GroupJ Morton, K Taylor, I Bunce, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Australian and New Zealand Journal of Ophthalmology|May 1, 1993
Interferon for subfoveal choroidal neovascularisationE Groeneveld, P Eliadis
Emergency Medicine (Fremantle, W.A.)|March 21, 2002
Angioedema in the emergency department: a presentation of lymphomaJ Wellwood, K Taylor, S Wright, et al.
Cancer Nursing|June 1, 1995
Psychosocial benefits of postmastectomy lymphedema therapyB R Mirolo, I H Bunce, M Chapman, et al.
Leukemia & Lymphoma|December 29, 1999
Long-term interferon-alpha 2A does not induce sustained hematologic remission in younger patients with essential thrombocythemiaM Bentley, K Taylor, A Grigg, et al.
Australian and New Zealand Journal of Medicine|April 14, 1999
Efficacy, safety and tolerability of anagrelide in the treatment of essential thrombocythaemiaA K Mills, K M Taylor, S J Wright, et al.
Leukemia Research|March 10, 1999
Safe mobilization of normal progenitors in advanced chronic myeloid leukemia with intensive chemotherapy and granulocyte-colony stimulating factorJ Morton, P Mollee, K Taylor, et al.
Leukemia|August 23, 2001
Effects of glycosylated recombinant human granulocyte colony-stimulating factor after high-dose cytarabine-based induction chemotherapy for adult acute myeloid leukaemiaK Bradstock, J Matthews, G Young, et al.
Leukemia & Lymphoma|September 24, 1999
A phase I/II study of intensive dose escalation of cytarabine in combination with idarubicin and etoposide in induction and consolidation treatment of adult acute myeloid leukemia. Australian Leukaemia Study Group (ALSG)R M Lowenthal, K F Bradstock, J P Matthews, et al.
British Journal of Haematology|October 1, 1996
High response rates with short infusional 2-chlorodeoxyadenosine in de novo and relapsed low-grade lymphoma. Australian and New Zealand Lymphoma Study GroupJ Morton, K Taylor, I Bunce, et al.
Pageof 1